Abstract: Objective To investigate the impact of hepatectomy or percutaneous transcatheter arterial chemoembolization (TAE) in treatment of patients with hepatic hemangioma on quality of life thereafter. Methods A total of 179 patients with hepatic hemangioma were admitted to our hospital between December 2015 and December 2017, and among them, 131 patients underwent hepatectomy (group A) and 48 patients received TAE (group B). The differences with respect to liver function index, renal function, operation time, intraoperative blood loss, postoperative complications, postoperative hospitalization stay and costs were compared. The patients' quality of life was assessed with the gastrointestinal quality of life index (GLQI).The materials were recorded in Epidata database. The statistical process was finished with SPSS 25.0 software. Results Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine levels in group A were significantly higher than those in group B (P <0.05) one week after operation; the operation time, intraoperative blood loss, postoperative hospital stay, and medical fees in group A were significantly higher or greater than those in group B (P<0.05); there was no statistical difference in total GLQI score between the two groups (P>0.05) at presentation, but the overall changing trend of the total GLQI scores after operation was significantly different between the two groups, which showed a continuous increase after operation in group A, and 12 months after operation, the total GLQI score was significantly higher than that in group B (P<0.05). Conclusion Hepatectomy has an exact curative effect on patients with hepatic hemangiomas, with a less incidence of adverse reactions, and might help improve patients’long-term quality of life.

Key words: Hepatic hemangioma, Hepatectomy, Transcatheter hepatic artery embolization, Quality of life